Early IGF-1 receptor inhibition in mice mimics preterm human brain disorders and reveals a therapeutic target
Science Advances · 2024
DOI: 10.1126/sciadv.adk8123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Alberto Potenzieri und 15 weiteren Autor:innen. Beteiligte Einrichtung: Brain Development and Disease Laboratory, Istituto Italiano di Tecnologia, via Morego, 30, 16163 Genoa, Italy. Hauptthemen laut MEDLINE: Insulin-Like Growth Factor I, Brain Diseases. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, European Research Council.
Abstract (Originalsprache)
Besides recent advances in neonatal care, preterm newborns still develop sex-biased behavioral alterations. Preterms fail to receive placental insulin-like growth factor-1 (IGF-1), a major fetal growth hormone in utero, and low IGF-1 serum levels correlate with preterm poor neurodevelopmental outcomes. Here, we mimicked IGF-1 deficiency of preterm newborns in mice by perinatal administration of an IGF-1 receptor antagonist. This resulted in sex-biased brain microstructural, functional, and behavioral alterations, resembling those of ex-preterm children, which we characterized performing parallel mouse/human behavioral tests. Pharmacological enhancement of GABAergic tonic inhibition by the U.S. Food and Drug Administration–approved drug ganaxolone rescued functional/behavioral alterations in mice. Establishing an unprecedented mouse model of prematurity, our work dissects the mechanisms at the core of abnormal behaviors and identifies a readily translatable therapeutic strategy for preterm brain disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Brain Development and Disease Laboratory, Istituto Italiano di Tecnologia, via Morego, 30, 16163 Genoa, Italy.
- Università degli Studi di Genova, via Balbi, 5, 16126 Genoa, Italy.
- Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, 16132 Genoa, Italy.
- Child Neuropsychiatry Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
- Patologia Neonatale, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
- Optical Approaches to Brain Function Laboratory, Istituto Italiano di Tecnologia, via Morego, 30, 16163 Genoa, Italy.
ORCID-Profile: Alberto Potenzieri, Deborah Preiti, Matteo Pisoni, Chiara Lavarello, Martina Bartolucci, Doriana Debellis, Federico Catalano, Andrea Petretto, Lino Nobili, Tommaso Fellin, Valter Tucci, Annalisa Savardi, Laura Cancedda
Förderung
- NINDS NIH HHS
- European Research Council
Zitieren
APA
Potenzieri, A., Uccella, S., Preiti, D., Pisoni, M., Rosati, S., Lavarello, C., Bartolucci, M., Debellis, D., Catalano, F., Petretto, A., Nobili, L., Fellin, T., Tucci, V., Ramenghi, L. A., Savardi, A., & Cancedda, L. (2024). Early IGF-1 receptor inhibition in mice mimics preterm human brain disorders and reveals a therapeutic target. Science Advances. https://doi.org/10.1126/sciadv.adk8123
Vancouver
Potenzieri A, Uccella S, Preiti D, Pisoni M, Rosati S, Lavarello C, et al. Early IGF-1 receptor inhibition in mice mimics preterm human brain disorders and reveals a therapeutic target. Science Advances. 2024. doi:10.1126/sciadv.adk8123
BibTeX
@article{Potenzieri2024,
author = {Potenzieri, Alberto and Uccella, Sara and Preiti, Deborah and Pisoni, Matteo and Rosati, Silvia and Lavarello, Chiara and Bartolucci, Martina and Debellis, Doriana and Catalano, Federico and Petretto, Andrea and Nobili, Lino and Fellin, Tommaso and Tucci, Valter and Ramenghi, Luca A and Savardi, Annalisa and Cancedda, Laura},
title = {Early IGF-1 receptor inhibition in mice mimics preterm human brain disorders and reveals a therapeutic target},
journal = {Science Advances},
year = {2024},
doi = {10.1126/sciadv.adk8123}
}
EUVIMED